Parexel International (PRXL) Stock Research, Analysis & News

Quick Analysis on Parexel International (PRXL) Stock as of August 6, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Parexel International (PRXL) Stock below)

Parexel International (PRXL) Stock Profile Summary

Parexel International Corporation, a biopharmaceutical services company, provides clinical research, medical communications, and consulting services, as well as advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. It operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management and biostatistics, data management, clinical logistics, and clinical pharmacology, as well as related medical advisory, patient recruitment, and investigator site services. It manages various aspects of clinical trials, such as study and protocol design, case report form design, site and investigator recruitment, patient enrollment, study monitoring and data collection, data analysis, report writing, and medical services. This segment provides services in therapeutic areas comprising cardiology, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics, psychiatry, and transplantation. The PCMS segment offers technical advice in areas, such as drug development, regulatory affairs, and biopharmaceutical process and management consulting. It also provides market and product development, and targeted communications services in support of product launch. In addition, its consultants identify alternatives and propose solutions to address clients product development, registration, and commercialization issues, as well as offers health policy consulting, and reimbursement and market access services. The Perceptive segment provides information technology solutions comprising medical imaging and systems integration services; RTSM, CTMS, and EDC products; Web-based portals; and patient diary applications. The company was founded in 1983 and is headquartered in Waltham, Massachusetts.

Parexel International (PRXL) Stock Key Statistics Research and Analysis as of August 6, 2020

Parexel International (PRXL) Stock Competitor Research and Analysis

Covance Inc. (CVD)Pharmaceutical Product Development Inc. (PPDI)

Mutual Funds with Parexel International (PRXL) Stock in its top 10 holdings

FundCategoryPRXL Holding Percentage
Aberdeen US Equity InstlLarge Blend2.84%
Aberdeen Small Cap RSmall Growth2.64%
Aberdeen US Equity ALarge Blend2.84%
Aberdeen US Equity Instl SvcLarge Blend2.84%
Hartford SmallCap Growth HLS IBSmall Growth0.93%

Stock Research on Parexel International (PRXL)

Latest Market News on Parexel International (PRXL)

Click here to find the latest news on Parexel International (PRXL)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Covance Inc. (CVD)
Pharmaceutical Product Development Inc. (PPDI)